In Depth 21 Feb 2025
The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Discover how biotech could solve the organ shortage crisis through xenotransplantation, 3D bioprinting and stem cells.
- Latest Posts
Podcast 21 Feb 2025
Can RNA drugs solve the obesity epidemic?
This week, we have a conversation with Alessandro Toniolo, CEO of Resalis Therapeutics, about a non-coding RNA drug candidate that promotes sustainable weight loss.
Best in Biotech 20 Feb 2025
3 promising biotech approaches to treat Hunter syndrome, a rare genetic disorder
Discover three promising approaches being investigated to treat Hunter syndrome, a rare genetic disorder affecting children.
News and Trends 19 Feb 2025
Trade war: how new U.S. tariffs will impact the biopharma industry
The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?
In Depth 18 Feb 2025
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer.
Why the right software is key to efficient trial design
Facing delays and inefficiencies in clinical trial design? Learn how the right software can solve key challenges and improve outcomes.
ADVERTISEMENT
ADVERTISEMENT
In Depth 17 Feb 2025
Biotech’s legal storm: Why securities class action lawsuits are surging
Find out about what’s behind the increase of securities class action lawsuits in the biotech industry and how to prevent them.
Podcast 14 Feb 2025
Reversing cancer mechanisms to fight back against solid tumors
This week, we have a conversation with Catalym’s Eugen Leo about Visugromab is a monoclonal antibody that neutralizes the tumor-derived growth differentiation factor-15.
Best in Biotech 13 Feb 2025
Seven companies using metabolomics to decode biology
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
News and Trends 13 Feb 2025
DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup
Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs.
In Depth 12 Feb 2025
Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates
Find out about the field of dendritic cell therapy, as several companies attempt to bring next-generation candidates through the clinic.
Best in Biotech 11 Feb 2025
12 ways biotechnology makes the world more sustainable
Biotech companies are turning to biology for solutions to make all aspects of our lives more sustainable for the environment.
ADVERTISEMENT
